Welcome. Please log in or create an account.

Advance care planning linked with longer survival in terminally ill patients

• Univadis Medical News
• 13 December 2019

The effects are strongest among those with diseases other than cancer.

Cancer risk in patients with atopic dermatitis

• Univadis Medical News
• 13 December 2019

Evidence suggests potential associations between atopic dermatitis and both increased and decreased cancer risks.

New platform to review unpublished studies

• Univadis Medical News
• 13 December 2019

The platform will expedite submission to 17 affiliate journals.

Ovarian cancer: weekly dose-dense chemotherapy vs standard care

• Univadis Medical News
• 13 December 2019

Results from the ICON8 trial have been published in the Lancet.

Over 300 children and adolescents die every day from AIDS-related causes

• Medical News
• 12 December 2019

Around 320 children and adolescents died every day from AIDS-related causes in 2018, according to a UNICEF snapshot.

SABCS 2019 – Adding S-1 to endocrine treatment improves survival in HR+, HER2− breast cancer

• Univadis
• 13 December 2019

Japanese phase 3 POTENT trial reported 39% reduction in disease recurrence.

SABCS 2019 – HER2+ breast cancer: add-on pertuzumab shows clinically relevant benefit in some patients

• Univadis
• 13 December 2019

4.5% increase in invasive DFS in node-positive subgroup did not meet significance but still relevant.

SABCS 2019 – HER2+ breast cancer: trastuzumab deruxtecan shines in DESTINY trial

• Univadis
• 13 December 2019

Achieves 15-month duration of response but deaths from interstitial lung disease remain a concern.